<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345681</url>
  </required_header>
  <id_info>
    <org_study_id>RC14_0268</org_study_id>
    <nct_id>NCT02345681</nct_id>
  </id_info>
  <brief_title>Impact of Rational Control of Fluid Balance in the Intensive Care Unit</brief_title>
  <acronym>IRIHS-REA</acronym>
  <official_title>Impact of Rational Control of Fluid Balance in the Intensive Care Unit.IRIHS-REA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <brief_summary>
    <textblock>
      Patients admitted in the Intensive Care Unit (ICU) frequently display and excessive fluid
      balance over a very short period of time. This positive fluid balance is the consequence of
      different organ failures (pulmonary, cardio-vascular, kidney…) or aggressive fluid
      resuscitation, which is mandatory in the early phase of ICU course. However recent data
      strongly suggest that an excessive fluid balance could be detrimental per se (increase of ICU
      morbidity or even mortality). There are controversies regarding the potential benefit of
      controlling this fluid balance with diuretics which are commonly used worldwide in various
      indications (acute and chronic heart failure, chronic kidney failure). In the ICU literature
      data are lacking, regarding the possible advantages and drawbacks of diuretics in this
      indication. The aim of our study is to test an algorithm with furosemide to reduce fluid
      overload in severe ICU-patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of fluid balance between randomisation and extubation (fluid balance in our study = Patient's weight at randomisation - Patient's initial weight (Kg) defined as the weight at admission)</measure>
    <time_frame>Day 60</time_frame>
    <description>Definition of fluid balance in our study = Patient's weight at randomisation - Patient's initial weight (Kg) defined as the weight at admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of ventilatory-free days</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of ICU-free days</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Period of mechanical Ventilation</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation Failure</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Period of stay</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Fluid Balance of ICU Patients</condition>
  <condition>Fluid Overload</condition>
  <arm_group>
    <arm_group_label>Test Furosemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We will test our furosemide algorithm in one arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classical Strategy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>It's a classical strategy without diuretics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furosemide</intervention_name>
    <arm_group_label>Test Furosemide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18 or more

          -  Patients receiving endo-tracheal intubation and mechanical ventilation during their
             stay in the ICU

          -  Weight increase of at least 3 % during the stay. Baseline weight is regarded as the
             weight at the 24th hour after ICU admission

          -  FiO2 &lt; 60 %, PEEP &lt; 10cmH20

          -  No administration of catecholamines other than dobutamine at a dose of 10
             microg.Kg-1.min-1

        Exclusion Criteria:

          -  Pregnancy

          -  Patient with a moribund state at ICU arrival

          -  Acute brain injury (traumatic brain injury, subarachnoid hemorrhage, intra-cerebral
             bleeding, stroke, meningo-encephalitis, coma from medication origin)

          -  Chronic kidney disease defined as creatinin clearance &lt; 30mL.min-1 and/or with chronic
             dialysis

          -  Mandatory administration of diuretics (cardiogenic pulmonary oedema, LVEF &lt; 30 %)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim Asehnoune</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU DE NANTES</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine LEBERT</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD La Roche sur Yon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karim Asehnoune</last_name>
    <email>karim.asehnoune@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital François Mitterand</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Pierre QUENOT</last_name>
      <email>jean-pierre.quenot@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine LEBERT</last_name>
    </contact>
    <investigator>
      <last_name>Christine LEBERT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karim ASEHNOUNE</last_name>
    </contact>
    <investigator>
      <last_name>Karim ASEHNOUNE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe GUITTON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand ROZEC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raphael CINOTTI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean REIGNIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>March 17, 2017</last_update_submitted>
  <last_update_submitted_qc>March 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>furosemide</keyword>
  <keyword>under strict conditions</keyword>
  <keyword>normalize</keyword>
  <keyword>ICU patients</keyword>
  <keyword>fluid balance</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

